TB-500 Peptide (Thymosin Beta-4): 5mg/ml Research Pen Guide 2026
Researching TB-500? This guide explains what the thymosin beta-4 fragment is, how it is studied in preclinical models, how it is compared with BPC-157, and how PrymaLab supplies it — a preloaded 3ml autoinjector pen at 5mg/ml for in-vitro and non-human research only.
Research-use-only disclaimer: TB-500 supplied by PrymaLab is a research-use-only material for in-vitro and non-human laboratory study. It is not for human or veterinary use and is not approved by the FDA to diagnose, treat, cure, or prevent any condition. Always verify the legal status of research compounds in your jurisdiction.
Quick Answer
What is TB-500? TB-500 is a synthetic peptide based on an active region of thymosin beta-4, a naturally occurring protein involved in actin regulation and cell migration. In preclinical research it is studied for tissue-repair and angiogenesis pathways. PrymaLab supplies it as a research-use-only 3ml pen at 5mg/ml.
This product is not for human or veterinary use; everything below describes laboratory and animal-model research only.
TB-500 is based on thymosin beta-4, a protein involved in actin binding, cell migration, and angiogenesis in research models.
PrymaLab format: a preloaded 3ml autoinjector pen at 5mg/ml for reproducible, traceable measured delivery.
TB-500 and BPC-157 are often studied together in tissue-repair research, but are structurally distinct molecules.
Research-use-only. TB-500 is not FDA-approved for human or veterinary use; published dosing refers to experimental models, not human protocols.
What Is TB-500?
TB-500 is a synthetic peptide based on an active region of thymosin beta-4, a naturally occurring 43-amino-acid protein. Thymosin beta-4 is best known in research for binding actin and participating in cell migration, and TB-500 is the synthetic fragment most commonly used to study those pathways.
For a laboratory, what is TB-500 comes down to a defined research compound supplied at a reference concentration. PrymaLab presents TB-500 at 5mg/ml in a sealed 3ml autoinjector pen so study teams can run reproducible in-vitro and non-human experiments.
How TB-500 Is Studied to Work
Preclinical literature discusses TB-500 and thymosin beta-4 in the context of actin regulation, cell migration, angiogenesis, and tissue-repair models. As with most research peptides, these mechanisms are observed primarily in animal and cell-culture studies and remain under active investigation rather than confirmed in humans.
Why Researchers Choose the PrymaLab TB-500 Autoinjector Pen
PrymaLab supplies TB-500 in a preloaded 3ml autoinjector pen calibrated to 5mg/ml, giving laboratories a uniform, repeatable format for in-vitro and non-human research. The sealed pen supports clean handling, measured delivery, and clear record-keeping across replicates.
- Fixed 5mg/ml reference concentration for reproducible study design.
- Measured delivery that reduces operator-to-operator variability.
- Optional glass reloading cylinder to standardize preparations between runs.
- Batch traceability linking every draw to a single reference batch.
PrymaLab TB-500 Specifications
| Specification | Detail |
|---|---|
| Compound | TB-500 (thymosin beta-4, tissue-repair peptide) |
| Form | Preloaded autoinjector pen (research-use-only) |
| Pen size | 3ml |
| Concentration | 5mg/ml |
| Optional accessory | Glass reloading cylinder for standardized refills |
| Intended use | In-vitro & non-human laboratory research only |
| Reference | PubChem compound record (Thymosin beta-4) |
How to Handle and Store the TB-500 Research Pen
Follow these laboratory handling steps when receiving and using the research-use-only TB-500 autoinjector pen. These describe lab handling only and are not human-use instructions.
- Receive and inspect. Confirm the TB-500 pen is sealed, the batch number is legible, and the solution is clear before logging it into inventory.
- Refrigerate and protect from light. Store the preloaded pen at 2-8°C away from light; avoid freeze-thaw cycles that can degrade the peptide.
- Record the batch. Log lot number, concentration (5mg/ml), and receipt date so each measured delivery traces to one reference batch.
- Dispense measured volumes. Use the measured-delivery mechanism to draw reproducible volumes into your in-vitro or non-human preparation, documenting each draw.
- Standardize with the reload cylinder. Where supplied, use the glass reloading cylinder to refill and keep the preparation consistent across replicates.
- Track stability and dispose. Record the open date, monitor working stability per protocol, and dispose of the research material via your laboratory chemical-waste process.
TB-500 vs BPC-157: How Researchers Compare Them
The phrase TB-500 and BPC-157 is one of the most common searches in this space because the two are frequently studied in parallel. They are, however, different molecules — the table summarizes how researchers distinguish them.
| Attribute | TB-500 (Thymosin beta-4) | BPC-157 |
|---|---|---|
| Molecule type | Synthetic fragment of thymosin beta-4 (43 aa protein) | Pentadecapeptide (15 aa) |
| Common research framing | Actin regulation, cell migration, angiogenesis | Body Protection Compound; gut & connective-tissue repair |
| Typical study pairing | Frequently studied alongside BPC-157 | Frequently studied alongside TB-500 |
| PrymaLab format | 3ml pen, 5mg/ml | 3ml pen, 5mg/ml |
| Status | Research-use-only | Research-use-only |
What the Research Studies: TB-500 “Benefits” in Context
Searches for TB-500 benefits usually mean: what have preclinical studies explored? In animal and in-vitro models, TB-500 and thymosin beta-4 research has examined areas including:
- Soft-tissue, tendon, and muscle repair models
- Cell migration and wound-closure assays
- Angiogenesis and microvascular response
- Cardiac and dermal tissue-repair research (thymosin beta-4)
These are research observations, not established human outcomes. PrymaLab makes no therapeutic claims and provides no human dosing guidance; any ‘TB-500 dosage’ figures in the literature refer to controlled experimental models.
TB-500 Side Effects & Legal Status in Research Settings
Reported TB-500 side effects derive from experimental models, and a complete human safety profile has not been established. TB-500 is not approved by the FDA for human or veterinary use and is handled as a research compound. Confirm the legal status of TB-500 in your jurisdiction before purchase.
Reminder: PrymaLab TB-500 is sold strictly for in-vitro and non-human laboratory research. It is not a drug, supplement, or medical device and must not be administered to humans or animals.
Looking for TB-500 in a consistent research format?
PrymaLab supplies TB-500 as a preloaded 3ml autoinjector pen at 5mg/ml, research-use-only, with transparent sourcing and batch traceability.
Frequently Asked Questions
What is TB-500?
TB-500 is a synthetic peptide based on an active region of thymosin beta-4, a protein involved in actin binding and cell migration. PrymaLab supplies it as a research-use-only 3ml autoinjector pen at 5mg/ml for in-vitro and non-human study. It is not for human or veterinary use.
What TB-500 benefits are studied in research?
In animal and in-vitro models, TB-500 and thymosin beta-4 have been studied for tissue repair, cell migration, and angiogenesis pathways. These are preclinical research observations only; no human therapeutic benefit is claimed and no human dosing is provided.
Does TB-500 have side effects?
Reported TB-500 side effects come from experimental models, and a full human safety profile has not been established. Because it is research-use-only and not approved for human use, TB-500 should be handled only by qualified researchers under laboratory controls.
What is the TB-500 dosage used in studies?
Published TB-500 dosage figures refer to controlled animal or in-vitro experiments, expressed per study design rather than as human protocols. PrymaLab supplies a 5mg/ml reference concentration and does not provide human dosing instructions.
TB-500 vs BPC-157 — what is the difference?
TB-500 is a synthetic fragment of the thymosin beta-4 protein, while BPC-157 is a 15-amino-acid pentadecapeptide. Both appear in tissue-repair research and are often compared, but they are distinct molecules. PrymaLab supplies both as research-use-only 3ml pens at 5mg/ml.
What concentration and format is PrymaLab TB-500?
PrymaLab TB-500 is supplied at 5mg/ml in a sealed, preloaded 3ml autoinjector pen, with an optional glass reloading cylinder for standardized refills between research runs.
Where can researchers buy TB-500 for research?
Qualified researchers can obtain TB-500 for research-use-only directly from PrymaLab at prymalab.net, supplied in the preloaded 3ml autoinjector pen format at 5mg/ml with batch traceability.
References & Further Reading
- PubChem Compound Summary, Thymosin beta-4. National Library of Medicine. pubchem.ncbi.nlm.nih.gov.
- Goldstein, A.L., et al. Thymosin beta-4: actin-sequestering protein and tissue-repair research (preclinical reviews).
- Lau, J.L., & Dunn, M.K. (2018). Therapeutic peptides: historical perspectives and development trends. Bioorganic & Medicinal Chemistry, 26(10), 2700–2707.
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers (research-compound status). FDA.gov.
- USP General Chapter <1225>. Validation of Compendial Procedures (HPLC purity-testing principles). United States Pharmacopeia.
Related research pages on PrymaLab: BPC-157 research pen · What is a peptide? · All research peptides
Final disclaimer: This product description is for educational and informational purposes only and is not medical advice. The compounds described by PrymaLab — including BPC-157, TB-500, NAD+, PT-141 (bremelanotide), Selank, and Semax — are sold strictly as research-use-only materials for in-vitro and non-human laboratory study. They are not approved by the FDA for human or veterinary therapeutic use, and statements about their effects have not been evaluated by the FDA. Nothing here is a recommendation to purchase, possess, or administer any compound to humans or animals.
Always consult a licensed professional and verify the legal status of any compound in your jurisdiction before purchase. PrymaLab supplies these materials for qualified researchers only and assumes no responsibility for misuse.
Reviews
There are no reviews yet.